These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Plasma dopamine beta hydroxylase activity in chronic schizophrenic patients tested with single dose of 2-bromo-alpha ergocriptine (Parlodel). Vardi J; Flechter S; Oberman Z; Segal R; Shogan G; Haker O Encephale; 1981; 7(1):95-103. PubMed ID: 7227288 [TBL] [Abstract][Full Text] [Related]
10. [The possible role of dopamine beta-monooxygenase in the pathogenesis of schizophrenia]. Mailian KR; Boiadzhian AS; Melik-Pashaian MA; Aĭvazian VA; Karagezian KG Dokl Akad Nauk; 1995 Jun; 342(6):833-4. PubMed ID: 7580969 [No Abstract] [Full Text] [Related]
11. [Relation among plasma dopamine beta-hydroxylase, monoamine oxidase and Cu++]. Stagni S; Mello P; Gualandi S; Guidi M; Illuminati B; Scanabissi E Boll Soc Ital Biol Sper; 1980 Aug; 56(15):1603-6. PubMed ID: 7459081 [TBL] [Abstract][Full Text] [Related]
12. Plasma dopamine-beta-hydroxylase in familial and sporadic paranoid schizophrenia. Markianos M; Rinieris P; Hatzimanolis J; Stefanis C Biol Psychiatry; 1990 May; 27(10):1176-8. PubMed ID: 2340326 [No Abstract] [Full Text] [Related]
13. Plasma DBH activity: relation to genetic factors in schizophrenia. Baron M; Levitt M; Perlman R Commun Psychopharmacol; 1980; 4(3):197-202. PubMed ID: 7226750 [No Abstract] [Full Text] [Related]
14. Plasma dopamine- -hydroxylase activity in hypertension and various neuropsychiatric disorders. Wetterberg L; Aberg H; Ross SB; Frödén O Scand J Clin Lab Invest; 1972 Nov; 30(3):283-9. PubMed ID: 4264461 [No Abstract] [Full Text] [Related]
15. Reduced serum dopamine-beta-hydroxylase activity in paranoid schizophrenics. Arató M; Bagdy G; Blümel F; Perényi A; Rihmer Z Pharmacopsychiatria; 1983 Jan; 16(1):19-22. PubMed ID: 6828551 [TBL] [Abstract][Full Text] [Related]
16. Neuroleptic-induced reductions in serum dopamine-beta-hydroxylase in schizophrenia. Goodnick PJ; Tong C; Duncavage MB; Meltzer HY Biol Psychiatry; 1983 Dec; 18(12):1485-8. PubMed ID: 6140962 [No Abstract] [Full Text] [Related]
17. Neuroleptic drug effect on plasma dopamine-beta-hydroxylase in schizophrenia. Baron M; Gruen R; Levitt M; Kane J Neuropsychobiology; 1982; 8(6):312-4. PubMed ID: 6131392 [TBL] [Abstract][Full Text] [Related]
18. [Proceedings: Serum dopamine beta hydroxylase activities in the insulin test]. Okada F; Yamashita I; Suwa N; Kunita H; Hata S Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):643. PubMed ID: 4476636 [No Abstract] [Full Text] [Related]
19. Changes in dopamine-beta-hydroxylase, and copper, and catecholamine concentrations in human plasma with physical exercise. Ohno H; Yahata T; Hirata F; Yamamura K; Doi R; Harada M; Taniguchi N J Sports Med Phys Fitness; 1984 Dec; 24(4):315-20. PubMed ID: 6533406 [No Abstract] [Full Text] [Related]